Impaired IL-15 production associated with susceptibility of murine AIDS to mycobacterial infection

Journal of Leukocyte Biology

Volumn 69, Issue 1, 2001, Pages 138-148

  Umemura, Masayuki ^a   Hirose, Kenji ^b   Wajjwalku, Worawidh ^c   Nishimura, Hitoshi ^a   Matsuguchi, Tetsuya ^a   Gotoh, Yoshitaka ^d   Takahashi, Masahide ^a   Makino, Masahiko ^e   Yoshikai, Yasunobu ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c KASETSART UNIVERSITY   (Thailand)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Infectious immunity; Interferon ; Interleukin 15; Macrophages; Mycobacterium boris BCG; T helper type1 cells

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EXUDATE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; INOCULATION; MOUSE; MURINE LEUKEMIA VIRUS; MYCOBACTERIUM BOVIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; TH1 CELL;

ANIMALS; DISEASE SUSCEPTIBILITY; FEMALE; INTERLEUKIN-15; LEUKEMIA VIRUS, MURINE; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; MYCOBACTERIUM BOVIS; TUBERCULOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MURINE LEUKEMIA VIRUS; MYCOBACTERIUM; MYCOBACTERIUM BORIS; MYCOBACTERIUM BOVIS BCG;

EID: 0035148811     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice
2. Characteristics of B cell proliferation and activation in murine AIDS
3. Retrovirus-induced murine acquired immunodeficiency syndrome: Natural history of infection and differing susceptibility of inbred mouse stains
4. A defective virus is associated with induction of a murine retrovirus induced immunodeficiency syndrome, MAIDS
5. Murine acquired immunodeficiency syndrome (MAIDS): An animal model to study the AIDS pathogenesis
6. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS
7. Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses
8. Cryptosporidiosis facilitated by murine retroviral infection with LP-BM5
9. Retrovirus-induced immunodeficiency in mice exacerbates gastrointestinal candidiasis
10. Opportunistic infections and retrovirus-induced immunodeficiency: Studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses
11. Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS)
12. Modulation of murine AIDS-related pathology by concurrent antibody treatment and coinfection with Leishmania major
13. + T cells protect mice with murine retrovirus-induced immunodeficiency syndrome (MAIDS) against co-infection with Listeria monocytogenes
14. Clonal expansion but lack of subsequent clonal deletion of bacterial superantigen-reactive T cells in murine retrovial infection
15. Immunity to intracellular bacteria
16. Why listeriosis? A perspective on cellular immunity to infection
17. The regulation of immunity to Leishmania major
18. T-cell immune responses in Mycobacterium avium infections in mice
19. The modifying effect of BCG on the immunological induction of T cells
20. Protective role of γ/δ T cells and α/β T cells in tuberculosis
21. Nontuberculous mycobacteria and associated diseases
22. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor
23. Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation
24. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
25. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15
26. IL-15 is a novel growth factor for murine γδ T cells induced by Salmonella infection
27. Intestinal epithelial cells both express and respond to interleukin 15
28. IL-15, an immunomodulator of T cell response in intracellular infection
29. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease
30. Interleukin-15 may be responsible for early activation of intestinal intraepithelial lymphocytes after oral infection with Listeria monocytogenes in rats
31. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
32. A potential role for IL-15 in the regulation of human natural killer cell survival
33. + T cells in vivo by IL-15
34. + T cell-mediated immunity against Toxoplasma gondii infection in mice
35. IL-15 enhances immune functions during HIV infection
36. Serum levels of IL-10, IL-15 and soluble tumor necrosis factor-alpha (TNF-α) receptors in type C chronic liver disease
37. Endogenous IL-15 might be responsible for early protection by natural killer cells against infection with avirulent strain of Salmonella choleraesuis in mice
38. Plaque assay techniques for routine leukemia viruses
39. Lymphomagenicity of recombinant milk cell focus-inducing murine leukemia viruses
40. Induction of γ/δ T cells in murine salmonellosis by an avirulent but not by a virulent strain of Salmonella choleraesuis
41. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
42. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
43. Up-regulation of T helper 2 and down-regulation of T helper 1 cytokines during murine retrovirus-induced immunodeficiency syndrome enhances susceptibility of a resistant mouse strain to Leishmania amazonensis
44. Mycobacterium avium complex infection in mice: Lack of exacerbation after LP-BM5 murine leukemia virus infection
45. Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses
46. Increased Fas antigen expression in murine retrovirus-induced immunodeficiency syndrome, MAIDS
47. The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells
48. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation
49. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β
50. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain
51. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain
52. Endogenous production of IL-15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro
53. Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Rα chain
54. IL-15/IL-15Rα intracellular trafficking in human cells and protection from apoptosis
55. IL-15 enhances the response of human γδ T cells to nonpetide microbial antigens
56. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
57. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
58. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages
59. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction
60. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance
61. The pathophysiology of tumor necrosis factors
62. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist
63. Regulation of interleukin-12 receptor β1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells
64. The NF-κB binding site is essential for transcriptional activation of the IL-15 gene
65. Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA
66. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells
67. Regulation of HIV-1 long terminal repeats by interaction of C/EBP (NF-IL6) and NF-κB/Rel transcription factors